This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Wilheim Kuhnz: Innovator in Testosterone Therapy
Introduction
Wilheim Kuhnz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of testosterone therapy. His work focuses on methods to achieve stable serum testosterone levels in patients with deficiencies.
Latest Patents
Kuhnz holds a patent for "Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels." This patent describes innovative methods for providing prolonged physiologically acceptable steady-state serum testosterone levels in patients deficient in endogenous testosterone. The methods also include approaches for male contraception and treatments for diseases associated with low testosterone levels, achieved through the intramuscular administration of testosterone esters in a suitable vehicle. He has 1 patent to his name.
Career Highlights
Wilheim Kuhnz is associated with Bayer Intellectual Property GmbH, where he has been instrumental in advancing research and development in hormone therapies. His expertise in pharmaceutical compositions has positioned him as a key figure in the industry.
Collaborations
Kuhnz has collaborated with notable colleagues, including Doris Hubler and Sabine Fricke, to further enhance the impact of his research and innovations.
Conclusion
Wilheim Kuhnz's contributions to testosterone therapy exemplify the importance of innovation in addressing medical needs. His work continues to influence the field of endocrinology and pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile